Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data.

BioMed research international - 1 Jan 2024

Esteves Luísa, Caramelo Francisco, Roda Domingos, Carreira Isabel Marques, Melo Joana Barbosa, Ribeiro Ilda Patrícia

Abstract excerpt

Glioblastoma multiforme (GBM) is the most prevalent type of brain tumour; although advancements in treatment have been made, the median survival time for GBM patients has persisted at 15 months. This study is aimed at investigating the genetic alterations and clinical features of GBM patients to find predictors of survival. GBM patients' methylation and gene expression data along with clinical information from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Mutation

Share to Prognosis

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 38606198
DOI: 10.1155/2024/5582424
PMCID: PMC11008977

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data.PMID 38606198Read ↗

Genomic, epigenomic and transcriptomic landscape of glioblastoma.Semantic proximity Read ↗

The identification of key genes and pathways in glioblastoma by bioinformatics analysisSemantic proximity Read ↗

Integrative Analysis of Dna Methylation and Gene Expression Profiles to Explore Potential Biomarkers of GlioblastomaSemantic proximity Read ↗

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastomaSemantic proximity Read ↗

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastomaSemantic proximity Read ↗

Clinical and molecular models of Glioblastoma multiforme survivalSemantic proximity Read ↗

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma MultiformeSemantic proximity Read ↗

Identification and Analysis of Molecular Pathways and Key Candidate Biomarkers in Glioblastoma MultiformeSemantic proximity Read ↗

Identification of new targets for glioblastoma therapy based on a DNA expression microarraySemantic proximity Read ↗

Identification of Potential Key Genes Associated with the Pathogenesis and Prognosis of Glioblastoma Based on Integrated Bioinformatics AnalysisSemantic proximity Read ↗

The genes significantly associated with an improved prognosis and long-term survival of glioblastomaSemantic proximity Read ↗

Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.